These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 4575803)

  • 1. Behavioral effects of drug therapy on psychogeriatric inpatients. I. Chlorpromazine and thioridazine.
    Altman H; Mehta D; Evenson RC; Sletten IW
    J Am Geriatr Soc; 1973 Jun; 21(6):241-8. PubMed ID: 4575803
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral effects of drug therapy on psychogeriatric inpatients. II. Multivitamin supplement.
    Altman H; Mehta D; Evenson RC; Sletten IW
    J Am Geriatr Soc; 1973 Jun; 21(6):249-52. PubMed ID: 4145685
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug treatment in newly admitted schizophrenic patients.
    Clark ML; Huber WK; Charalampous KD; Serafetinides EA; Trousdale W; Colmore JP
    Arch Gen Psychiatry; 1971 Nov; 25(5):404-9. PubMed ID: 4943915
    [No Abstract]   [Full Text] [Related]  

  • 4. Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study.
    Tsuang MM; Lu LM; Stotsky BA; Cole JO
    J Am Geriatr Soc; 1971 Jul; 19(7):593-600. PubMed ID: 4937658
    [No Abstract]   [Full Text] [Related]  

  • 5. Antipsychotic treatment in outpatients with dementia.
    Devanand DP
    Int Psychogeriatr; 1996; 8 Suppl 3():355-61; discussion 381-2. PubMed ID: 9154588
    [No Abstract]   [Full Text] [Related]  

  • 6. Intermittent pharmacotherapy in chronic schizophrenia.
    Prien RF; Gillis RD; Caffey EM
    Hosp Community Psychiatry; 1973 May; 24(5):317-22. PubMed ID: 4574574
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentiation of phenothiazines by -methyltyrosine in treatment of chronic schizophrenia.
    Carlsson A; Persson T; Roos BE; Wålinder J
    J Neural Transm; 1972; 33(2):83-90. PubMed ID: 4345237
    [No Abstract]   [Full Text] [Related]  

  • 8. [A double-blind controlled study of the efficacy and side effects of thioridazine and chlorpromazine in schizophrenia].
    Guo GY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):300-2, 319-20. PubMed ID: 3234163
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia.
    Weston MJ; Bentley R; Unwin A; Morris M; Harper MA
    Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393
    [No Abstract]   [Full Text] [Related]  

  • 10. Are antipsychotic drugs interchangeable?
    Gardos G
    J Nerv Ment Dis; 1974 Nov; 159(5):343-8. PubMed ID: 4612111
    [No Abstract]   [Full Text] [Related]  

  • 11. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loxapine versus thioridazine in the treatment of organic psychosis.
    Versiani M; da Silva JA; Mundim FD
    J Int Med Res; 1980; 8(1):22-30. PubMed ID: 7358200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential response to parenteral chlorpromazine and mesoridazine in psychotic patients.
    Brauzer B; Goldstein BJ
    J Clin Pharmacol J New Drugs; 1970; 10(2):126-31. PubMed ID: 4906541
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral symptoms in dementia: community-based research.
    Auer SR; Monteiro IM; Reisberg B
    Int Psychogeriatr; 1996; 8 Suppl 3():363-6; discussion 381-2. PubMed ID: 9154589
    [No Abstract]   [Full Text] [Related]  

  • 15. Loxapine: a double-blind comparison with chlorpromazine in acute schizophrenic patients.
    Steinbook RM; Goldstein BJ; Brauzer B; Moreno SS; Jacobson AF
    Curr Ther Res Clin Exp; 1973 Jan; 15(1):1-7. PubMed ID: 4631378
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine antagonism by thioridazine in schizophrenia.
    Meltzer HY; Sachar EJ; Frantz AG
    Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting response to phenothiazines: the right drug for the right patient.
    Galbrecht CR; Klett CJ
    J Nerv Ment Dis; 1968 Aug; 147(2):173-83. PubMed ID: 5677325
    [No Abstract]   [Full Text] [Related]  

  • 18. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract]   [Full Text] [Related]  

  • 19. Alleviating agitation, apprehension, and related symptoms in geriatric patients: A double-blind comparison of a phenothiazine and a benzodiazepien.
    Covington JS
    South Med J; 1975 Jun; 68(6):719-24. PubMed ID: 1094544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of thioridazine and chlorpromazine in doctor's choice research design.
    Kimbell I; Winkelman GW; Hughes WM
    Clin Pharmacol Ther; 1971; 12(5):825-32. PubMed ID: 4936147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.